$PRME might be the stock to buy for 2026: < Best Prime Editing platform: precise “search-and-replace” gene editing that can fix 90% of known disease mutations with superior safety and versatility vs CRISPR/base editors < High value in vivo liver programs (Wilson’s Disease PM577

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin